Offering access to our products to the maximum number of patients throughout the world
Reducing the barriers that prevent access to our products, in order to reach a maximum amount of patients who benefit from our treatments.
A real patient-centric business model
Our priority is to develop medicines and diagnostics that significantly improve patient’s lives. We take actions to extend patients reach in countries where access to healthcare is a complex challenge. We are committed to bring our products where people need them.
Extending Patient reach
Extending the indications to treat more patients
In addition to treat prostate cancer, Triptoreline is now delivered to children and women as a treatment for CPP (Central Precoce Puberty) and endometriosis. It has recently been available in Switzerland to treat patients with breast cancer.
Offering preferential prices
To adapt to the market: India, Asia
Reaching developing countries
Since 2015, we are committed to work with different key partners to commercialize Triptoreline outside Europe, the USA and other developed countries. We are now focusing on developing countries. A recent example is Indonesia which is covered since autumn 2021
Adding true value to patients with unmet needs
Our investment in antibiotics
We believe in the urgent need for new antibiotics to respond to the rising threat of bacterial epidemics. Antibiotic development is quite costly yet market prices remain low, discouraging research investment. Despite this issue, we still aim to develop new antibacterial treatments in response to the urgent need while remaining hopeful that a new business model will emerge.
Donation to the EOCRT
We support the European Organisation for Cancer Research and Treatment in their research on ultra-rare diseases such salivary gland cancer
Even after a clinical trial is over, we continue providing treatment to patients who have been enrolled in clinical studies and who have responded well
A strong patient centric approach
Providing information to patients
We offer disease education and clinical trial information on one of our sites, encouraging people to speak to their doctors about any appropriate research in their region
Understanding patient needs
We organize « Patient Days » to help employees to better understand patient experience and their actual needs through conferences. Patients are invited to share their disease journey with Debiopharm employees